{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_6348", "batch_size": 200, "batch_pos": 173, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "'said' and 'begin' are neutral verbs.", "method": "llm_batch", "batch_id": "batch_2_5528", "batch_size": 200, "batch_pos": 133, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment discusses future testing plans, not realised impact with moderate verbs and scale.", "method": "llm_batch", "batch_id": "batch_3_19308", "batch_size": 200, "batch_pos": 83, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a question.", "method": "llm_batch", "batch_id": "batch_4_17164", "batch_size": 200, "batch_pos": 69, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "The segment reports trial timeline, lacking explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_18596", "batch_size": 200, "batch_pos": 62, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment describes trial timeline but does not use a minimiser with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_17472", "batch_size": 200, "batch_pos": 23, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "The segment describes testing timeline, not a bare negation.", "method": "llm_batch", "batch_id": "batch_7_3220", "batch_size": 200, "batch_pos": 16, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
{"Q": 8, "answer": "yes", "rationale": "Describes a future action/development step: 'late-stage testing would begin in 2025'.", "method": "llm_batch", "batch_id": "batch_8_4648", "batch_size": 200, "batch_pos": 95, "statement_text": "U.S. officials said on a press call that late-stage testing would begin in 2025, pending results expected in the coming weeks of Moderna's phase 1 trial.", "article_id": 1745}
